Treace John T.'s Form 4 filing
Treace Medical Concepts, Inc. (TMCI) · filed Oct 22, 2021
- Accession no.
- 0001567619-21-018627
- Filed
- Oct 22, 2021
- Trade date
- Sep 7-Oct 22, 2021
- Filing delay
- 45 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions. Open-market sales total $3.55M. It was filed 45 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Treace John T.CIK 0001856380 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 20, 2021 | Common Stock | SSaleDisposed | −22,612 | $24.79F2 | −$560,551.48 | 5,894,968 | Direct | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −8,215 | $25.37F3 | −$208,414.55 | 5,886,753 | Direct | |
| Oct 21, 2021 | Common Stock | SSaleDisposed | −34,325 | $19.89F4 | −$682,724.25 | 5,852,428 | Direct | |
| Oct 21, 2021 | Common Stock | SSaleDisposed | −26,701 | $20.67F5 | −$551,909.67 | 5,825,727 | Direct | |
| Oct 21, 2021 | Common Stock | SSaleDisposed | −2,768 | $21.49F6 | −$59,484.32 | 5,822,959 | Direct | |
| Oct 21, 2021 | Common Stock | SSaleDisposed | −8,207 | $23.07F7 | −$189,335.49 | 5,814,752 | Direct | |
| Oct 21, 2021 | Common Stock | SSaleDisposed | −4,044 | $23.86F8 | −$96,489.84 | 5,810,708 | Direct | |
| Oct 21, 2021 | Common Stock | SSaleDisposed | −39 | $24.50 | −$955.5 | 5,810,669 | Direct | |
| Oct 22, 2021 | Common Stock | SSaleDisposed | −57,534 | $20.74F9 | −$1,193,255.16 | 5,753,135 | Direct | |
| Oct 22, 2021 | Common Stock | SSaleDisposed | −555 | $21.16F10 | −$11,743.8 | 5,752,580 | Direct | |
| Sep 7, 2021 | Common Stock | AGrant or awardAcquired | +408,816 | $0.00 | $0 | 408,816 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.21 to $25.21 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.22 to $25.69 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.21 to $20.21 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.22 to $21.16 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.30 to $21.98 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.37 to $23.36 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.38 to $24.25 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.12 to $21.03 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.14 to $21.21 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.